AU3913800A - Novel antioxidant formulations and methods for using them - Google Patents

Novel antioxidant formulations and methods for using them

Info

Publication number
AU3913800A
AU3913800A AU39138/00A AU3913800A AU3913800A AU 3913800 A AU3913800 A AU 3913800A AU 39138/00 A AU39138/00 A AU 39138/00A AU 3913800 A AU3913800 A AU 3913800A AU 3913800 A AU3913800 A AU 3913800A
Authority
AU
Australia
Prior art keywords
methods
novel antioxidant
antioxidant formulations
formulations
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39138/00A
Inventor
Timothy Avila
Ronald H Lane
F. Howard Schneider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lipogenics Inc
Original Assignee
Lipogenics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipogenics Inc filed Critical Lipogenics Inc
Publication of AU3913800A publication Critical patent/AU3913800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
AU39138/00A 1999-03-26 2000-03-24 Novel antioxidant formulations and methods for using them Abandoned AU3913800A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12625599P 1999-03-26 1999-03-26
US60126255 1999-03-26
PCT/US2000/007733 WO2000057876A1 (en) 1999-03-26 2000-03-24 Novel antioxidant formulations and methods for using them

Publications (1)

Publication Number Publication Date
AU3913800A true AU3913800A (en) 2000-10-16

Family

ID=22423840

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39138/00A Abandoned AU3913800A (en) 1999-03-26 2000-03-24 Novel antioxidant formulations and methods for using them

Country Status (2)

Country Link
AU (1) AU3913800A (en)
WO (1) WO2000057876A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000078296A2 (en) * 1999-06-17 2000-12-28 Basf Aktiengesellschaft Tocotrienol and/or tocotrienol derivatives for the treatment or prophylaxis of glutamate- and/or calcium-induced disorders
GB0026018D0 (en) 2000-10-24 2000-12-13 Novartis Nutrition Ag New composition
EP1339404A2 (en) * 2000-10-31 2003-09-03 Colgate-Palmolive Company Composition and method
US6608103B2 (en) 2001-02-08 2003-08-19 Fuji Chemical Industry Co., Ltd. Inhibitor for neovasculation, cell multiplication, lumen formation and FGF
AU2002327517B2 (en) 2001-08-21 2008-04-17 Johnson & Johnson Consumer Companies, Inc. Tocopherol enriched compositions and amelioration of inflammatory symptoms
EP1374882B1 (en) * 2002-06-19 2008-10-01 Cognis IP Management GmbH Use of mixtures of active ingredients for the manufacture of a medicament for the treatment of rheumatoid arthritis
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
AU2003900200A0 (en) * 2003-01-17 2003-01-30 Vital Health Sciences Pty Ltd Compounds having antiproliferative properties
WO2004064831A1 (en) * 2003-01-17 2004-08-05 Vital Health Sciences Pty Ltd Compounds having anti-proliferative properties
EP1591118A1 (en) * 2004-04-27 2005-11-02 Nutri-Fit GmbH & Co. KG Use of melatonin in preventing postoperative complications
WO2006053010A2 (en) * 2004-11-09 2006-05-18 Hill's Pet Nutrition, Inc. Use of antioxidants for gene modulation
NZ565049A (en) 2005-06-17 2012-02-24 Vital Health Sciences Pty Ltd A carrier comprising one or more DI and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
ITRM20060108A1 (en) 2006-03-03 2007-09-04 Colella Gino MELATONIN-BASED COMPOSITIONS AND IMMUNOSTIMULATING SUBSTANCES
US10071030B2 (en) 2010-02-05 2018-09-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
ES2829386T3 (en) 2010-03-30 2021-05-31 Phosphagenics Ltd Transdermal administration patch
EP2389931A1 (en) * 2010-05-21 2011-11-30 Raw Materials Internatinal LLC Pharmaceutical aqueous compositions comprising lipoic acid as an antioxidant
US20110293753A1 (en) * 2010-05-28 2011-12-01 Louis Bellafiore Tocotrienol Compositions
WO2012122586A1 (en) 2011-03-15 2012-09-20 Phosphagenics Limited New composition
WO2017096427A1 (en) 2015-12-09 2017-06-15 Phosphagenics Limited Pharmaceutical formulation
EP3558903A4 (en) 2016-12-21 2019-11-27 Avecho Biotechnology Limited Process
WO2018211297A1 (en) * 2017-05-18 2018-11-22 Pacini Nicola Improved dermatological formulations for cosmetic and pharmacological use, and cosmetic and pharmacological product prepared by means of said formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2124086A1 (en) * 1991-11-22 1993-05-27 Ronald H. Lane Tocotrienols and tocotrienol-like compounds and methods for their use
US5376361A (en) * 1993-01-13 1994-12-27 Perricone; Nicholas V. Method and compositions for topical application to the skin for prevention and/or treatment of radiation-induced skin damage
US5545398A (en) * 1993-01-13 1996-08-13 Perricone; Nicholos V. Method and compositions for topical application to the skin of tocotrienol for prevention and/or treatment of skin damage
DE4444238A1 (en) * 1994-12-13 1996-06-20 Beiersdorf Ag Cosmetic or dermatological drug combinations of cinnamic acid derivatives and flavone glycosides
US5709868A (en) * 1995-09-20 1998-01-20 Perricone; Nicholas V. Lipoic acid in topical compositions
US5834513A (en) * 1996-04-25 1998-11-10 Avon Products, Inc. Oxa diacids and related compounds for treating skin conditions

Also Published As

Publication number Publication date
WO2000057876A1 (en) 2000-10-05

Similar Documents

Publication Publication Date Title
AUPQ419099A0 (en) Novel compositions and methods
AU3913800A (en) Novel antioxidant formulations and methods for using them
AU5139600A (en) Nutritional formulations
AU3243300A (en) Multiparticulate formulation
AU3867400A (en) Methods of using bioelastomers
AU6310000A (en) Aerosol formulations
AU7989400A (en) Compounds and methods
AU3215500A (en) Compounds and methods
AUPQ441699A0 (en) Pour-on formulations
AU5326100A (en) Pharmaceutical compositions and methods for use
AU4318000A (en) Agarobiose-containing composition
AU5565099A (en) Pharmaceutical compositions and methods for use
AUPP968699A0 (en) Therapeutic compositions and method for their preparation
AU1290501A (en) Composition
AU2184099A (en) Insecticidal compositions and insecticidal methods
AU5272700A (en) Adjustable earring
AU5643300A (en) An adjustable framework for containing objects
AU6715600A (en) Pharmaceutical formulations
AUPQ147699A0 (en) Sunscreen formulations
AU7474100A (en) Methods and compositions for reducing immune response
AU7816000A (en) Pediculocidal and veterinary compositions
AU4977300A (en) Pharmaceutical formulations
AU5544500A (en) Livin; inhibitor-of-apoptosis protein-3 (iap-3)
AU4779400A (en) Hair-treatment composition
AU1385801A (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase